Does myeloablative BuMel therapy improve survival of poor-risk localized tumor of the Ewing family (ET)? Experience of the French Society of Pediatric Oncology (SFOP)

✍ Scribed by Oberlin, O.; Hartmann, O.; Bergeron, C.; Rubie, H.; Baranzelli, M.C.; Boutard, P.; Lejars, O.; Michon, J.

• Book ID: 122981284
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 179 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(01)81743-3